Skip to content

Organon OGN Financing Cash Flow

Financing Cash Flow at other companies

Pfizer logo
PfizerPFE
-$2.86B+45.4%
Amgen logo
AmgenAMGN
$1.44B+135%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$75.8M-781%
Biogen logo
BiogenBIIB
-$43.8M-90.4%
AbbVie logo
AbbVieABBV
$919M+173%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$59.06M-50.8%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's financing cash flow?
Organon (OGN) reported financing cash flow of -$38M in Q1 2026.
How has Organon's financing cash flow changed year-over-year?
Organon's financing cash flow increased by 49.3% year-over-year, from -$75M to -$38M.
What is the long-term trend for Organon's financing cash flow?
Over 3 years (2022 to 2025), Organon's financing cash flow has grown at a 9.0% compound annual growth rate (CAGR), from -$433M to -$561M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.